ArticleFrontiers in public health2024
Development of a machine learning tool to predict the risk of incident chronic kidney disease using health examination data.
Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- GERBEHRT: a BERT-based model tailored for German electronic health records - potential in chronic kidney disease prediction.BMC medical informatics and decision making · 2026Article
- Applications of Machine Learning for Early Diagnosis and Prognosis of Chronic Kidney Disease: Current Evidence.Diagnostics (Basel, Switzerland) · 2026Review
- Development and internal validation of an interpretable machine learning model for predicting dialysis risk in patients with stage 3-4 chronic kidney disease.Frontiers in public health · 2026Article
- The evaluation of indoxyl sulfate in the general population in Kanegasaki Iwate: A cross-sectional study (KANEGASAKI study).PloS one · 2025Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic kidney disease (CKD) is characterized by a decreased glomerular filtration rate or renal injury (especially proteinuria) for at least 3 months. The early detection and treatment of CKD, a major global public health concern, before the onset of symptoms is important. This study aimed to develop machine learning models to predict the risk of developing CKD within 1 and 5 years using health examination data. Methods: Data were collected from patients who underwent annual health examinations between 2017 and 2022. Among the 30,273 participants included in the study, 1,372 had CKD. Demographic characteristics, body mass index, blood pressure, blood and urine test results, and questionnaire responses were used to predict the risk of CKD development at 1 and 5 years. This study examined three outcomes: incident estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m Results: All models had predictive values, sensitivities, and specificities >0.8 for predicting the onset of CKD in 1 year when the outcome was eGFR <60 mL/min/1.73 m Conclusion: Machine learning models can predict the risk of CKD, and eGFR plays a crucial role in predicting the onset of CKD. However, it is difficult to predict the onset of proteinuria based solely on health examination data. Further studies must be conducted to predict the decline in eGFR and increase in urine protein levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.